Attention-deficit/hyperactivity disorder medication and risk of suicide attempt: A meta-analysis of observational studies

摘要

Purpose: Epidemiologic findings are inconsistent regarding the association between attention-deficit/hyperactivity disorder (ADHD) medication exposure and suicide attempt in individuals with ADHD. Methods: A systematic literature search of PubMed, Embase and Cochrane Library up to February 2020 was performed. A meta-analysis was conducted for outcomes in which a summary risk ratio (RR) was calculated when taking heterogeneity into account. Results: Both population-level and within-individual analyzes showed that ADHD medication was associated with lower odds of suicide attempts (RR = 0.76, 95 confidence interval Cl, 0.58-1.00; P = .049 and RR = 0.69; 95 Cl, 0.49-0.97; P = .049, respectively). However, the association only existed for participants who were treated with stimulants (RR = 0.72; 95 Cl, 0.53-0.99; P = .042 on population-level analysis and RR = 0.75; 95 Cl, 0.66-0.84; P < .001 on within-individual analysis). Furthermore, a lower risk of suicide attempts was not observed in subjects who took ADHD medication for 1 to 90 days (RR = 0.91; 95 Cl, 0.74-1.13; P = .416 on within-individual analysis). Conclusion: The results indicate that non-stimulant treatment is not associated with a higher risk of suicide attempt, but stimulant treatment is associated with a lower risk of suicide attempt.